Precision BioSciences, Inc. (DTIL): Price and Financial Metrics
DTIL Price/Volume Stats
| Current price | $4.72 | 52-week high | $19.43 |
| Prev. close | $4.60 | 52-week low | $4.13 |
| Day low | $4.51 | Volume | 705,500 |
| Day high | $5.01 | Avg. volume | 83,580 |
| 50-day MA | $7.35 | Dividend yield | N/A |
| 200-day MA | $9.90 | Market Cap | 36.21M |
DTIL Stock Price Chart Interactive Chart >
Precision BioSciences, Inc. (DTIL) Company Bio
Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's propriety genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane in January 2006 and is headquartered in Durham, NC.
DTIL Price Returns
| 1-mo | -27.38% |
| 3-mo | -50.88% |
| 6-mo | -50.21% |
| 1-year | -57.50% |
| 3-year | -98.06% |
| 5-year | -98.94% |
| YTD | -56.89% |
| 2023 | -69.33% |
| 2022 | -83.92% |
| 2021 | -11.27% |
| 2020 | -39.96% |
| 2019 | N/A |
Loading social stream, please wait...